Science
The race to make COVID antibody therapies cheaper and more potent – Nature.com
Injections of antibodies might prevent mild COVID-19 from becoming severe, but the treatments are expensive and difficult to make.
Human antibodies attacking the coronavirus (artist’s impression).Credit: Science Lab/Alamy
When US President Donald Trump was ill with COVID-19, his physicians administered a bevy of medications some proven, others experimental. But there is one that the president has hailed as a cure: a cocktail of coronavirus antibodies produced by Regeneron Pharmaceuticals in Tarrytown, New York.
The ‘curative’ power of this antibody treatment has yet to be proven. Although it has shown promise in small, early…
-
Business18 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News14 hours agoTips to improve engagement – Proctor
-
General24 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz